Richard Christopher as Chief Financial Officer

InVivo Therapeutics Announces Richard Christopher as CFO and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 14, 2019  CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq:NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus…